908 Devices Inc. has appointed co-founder Christopher D. Brown, Ph.D., to its board. He currently works as vice president of Analytics R&D at Repligen Corporation.

“Chris played a pivotal role in shaping our product strategy and assembling the team that continues to advance our technology today,” 908 Devices Co-Founder/CEO Kevin J. Knopp said. “I’m excited that we can continue to benefit from his expertise, vision, and leadership in his new role on the Board.”

In addition to co-foundeding 908 Devices, Dr. Brown was the company’s chief technology officer and vice president of Research & Development from February 2012 to March 2023, and chief product officer from March 2023 until March 2025, when Repligen purchased the company’s bioprocessing portfolio.

Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc., leading investigations in future-gen health technologies. Before joining Apple (April 2010 to October 2010), he was senior director at Thermo Fisher Scientific Inc. and from 2005 until 2010 he led product development and engineering at Ahura Scientific, which was acquired by Thermo Fisher Scientific.

Dr. Brown earned a bachelor’s degree in mathematics and chemistry from Brandon University, and a Ph.D. in chemistry from Dalhousie University, where he specialized in statistical and machine learning methods for chemical data.

“I’m delighted that Chris is now a board member,” 908 Devices Board Chairman Kevin Hrusovsky stated. “His expertise in advanced analytical technologies and longstanding commitment to innovation will be a valuable asset to the board and to the company.”

908 Devices aims to improve chemical analysis with its simple handheld devices that address life-altering applications. The company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in vital health and safety applications, such as the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The company is headquartered in Boston, where it designs and manufactures products that bring together the power of complementary analytical technologies, software automation, and machine learning.